The therapeutic success of approaches to the gastrointestinal microbiome modulation in the treatment of obesity, metabolic syndrome and type 2 diabetes mellitus
Obesity, type 2 diabetes mellitus (T2DM), and related metabolic disorders occupy the leading positions on the lists of diseases worldwide. It is not surprising that the efforts of many scientific groups and clinicians are aimed at finding effective therapeutic strategies to treat these diseases. In...
Saved in:
| Main Authors: | A. A. Zabolotneva, O. P. Shatova, J. A. Agapova, A. S. Romanenko, S. A. Roumiantsev, A. V. Shestopalov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Endocrinology Research Centre
2025-01-01
|
| Series: | Сахарный диабет |
| Subjects: | |
| Online Access: | https://www.dia-endojournals.ru/jour/article/view/13196 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Possibilities and Prospects of Modification of the Intestinal Microbiome
by: E. G. Malaeva, et al.
Published: (2022-10-01) -
The associations of incretin hormone concentration with gestational diabetes mellitus
by: Tatiana V. Saprina, et al.
Published: (2016-05-01) -
Gut microbiome dynamics of patients on dialysis: implications for complications and treatment
by: Changlin Li, et al.
Published: (2025-04-01) -
New glance at pathogenesis of type 2 diabetes mellitus: incretin and antiincretin systems.
by: Ekaterina Alekseevna Shestakova
Published: (2011-09-01) -
The Role of the Microbiome in the Pathogenesis, Phenotype, and Treatment of Asthma
by: Safia Gul, et al.
Published: (2025-04-01)